A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
about
A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen).Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignanciesRecent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer.Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials.Pharmacokinetics of the antineoplastic drug mitomycin C in regional chemotherapy using the aortic stop flow technique in advanced pancreatic carcinoma.HER family inhibitors in pancreatic cancer: current status and future directions.UA62784, a novel inhibitor of centromere protein E kinesin-like proteinPhase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors.Phase II clinical trial of paclitaxel loaded polymeric micelle in patients with advanced pancreatic cancer.Phase I trial using weekly administration of gemcitabine and docetaxel in patients with advanced pancreatic carcinoma.A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.Gemcitabine combined with docetaxel for the treatment of unresectable pancreatic carcinoma.Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer.Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts.
P2860
Q33395577-9C386514-CF79-4DE6-A91B-B4DFF05CA588Q33423203-861930AA-D176-43DF-AD16-874F20010C7FQ33632330-107C3497-1AC7-4F1B-B596-488CFAE4482FQ33891037-777E042F-949B-44E8-96DA-781F9C1FAC90Q36049996-04964916-82A1-453C-8A1B-A2397F98D989Q36734936-449D47E9-8ADD-4FF2-B98A-9E4D2BA9C564Q37081499-055E4158-6874-4827-A0B7-2DDC664F4D26Q37634058-03B01C73-1AC9-4375-8277-2D4668532E69Q39921592-CDCF5733-ED4A-4573-B03F-36A3B6086CE7Q40460037-ED175B1D-ABF1-4422-B1F3-58E5D253B9DCQ43869761-D2425E95-93F0-4D9A-BC26-503AB0225BD3Q44906700-109027E4-BAA4-4D18-8488-908334806928Q46623057-3EFA6CE1-1319-4832-A5D6-C3F546E72A9AQ46941754-75A6A7EB-DF76-4C86-9FA3-FB6FAECC306B
P2860
A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A phase I-II study of gemcitab ...... gestive Tract Cancer (GISCAD).
@ast
A phase I-II study of gemcitab ...... gestive Tract Cancer (GISCAD).
@en
A phase I-II study of gemcitab ...... tudy of Digestive Tract Cancer
@nl
type
label
A phase I-II study of gemcitab ...... gestive Tract Cancer (GISCAD).
@ast
A phase I-II study of gemcitab ...... gestive Tract Cancer (GISCAD).
@en
A phase I-II study of gemcitab ...... tudy of Digestive Tract Cancer
@nl
prefLabel
A phase I-II study of gemcitab ...... gestive Tract Cancer (GISCAD).
@ast
A phase I-II study of gemcitab ...... gestive Tract Cancer (GISCAD).
@en
A phase I-II study of gemcitab ...... tudy of Digestive Tract Cancer
@nl
P2093
P356
P1433
P1476
A phase I-II study of gemcitab ...... gestive Tract Cancer (GISCAD).
@en
P2093
G Catalano
G Gasparini
P Giordani
V Catalano
P304
P356
10.1023/A:1008394111533
P577
1999-11-01T00:00:00Z